1350426-22-0

Upstream product

• 1350425-96-5 6-chloro-N²-(quinolin-6-ylmethyl)pyridine-2,3-diamine 
• 1350425-92-1 6-chloro-3-nitro-N-(quinolin-6-ylmethyl)pyridin-2-amine 
• 5382-43-4 quinoline-6-carboxamide 
• 38896-30-9 6-(methoxycarbonyl)quinoline 
• 10349-57-2 Quinoline-6-carboxylic acid 
• 150-13-0 4-amino-benzoic acid 
• 99071-54-2 quinolin-6-ylmethanamine 
• 1313726-84-9 6-((5-chloro-3H-[1,2,3]triazolo[4,5-b]pyridin-3-yl)methyl)quinoline 
• 5720-07-0 4-methoxyphenylboronic acid 
• 23395-72-4 quinoline-6-carbonitrile 

Relevant academic research and scientific papers

NOVEL 3,5-DISUBSTITUTED-3H-IMIDAZO[4,5-B]PYRIDINE AND 3,5- DISUBSTITUTED -3H-[1,2,3]TRIAZOLO[4,5-B] PYRIDINE COMPOUNDS AS MODULATORS OF PROTEIN KINASES

The present invention provides, inter alia, compounds of formula I as protein kinase modulators, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of kinase mediated diseases or disorders with them.

NOVEL 3,5-DISUBSTITUED-3H-IMIDAZO[4,5-B]PYRIDINE AND 3,5- DISUBSTITUED -3H-[1,2,3]TRIAZOLO[4,5-B] PYRIDINE COMPOUNDS AS MODULATORS OF PROTEIN KINASES

The present invention provides, inter alia, compounds of formula ΙΑ,ΙΙΑ and III as protein kinase modulators, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of kinase mediated diseases or disorders with them.